Cargando…

The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review

BACKGROUND: It is unclear if the use of hormone therapy (HT) in carriers of BRCA mutations improves the quality of life (QOL) without increasing the risk of breast cancer following a risk-reducing salpingo-oophorectomy (RRSO). Our objective was to assess the effect of HT on QOL and breast cancer ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siyam, Tasneem, Ross, Sue, Campbell, Sandra, Eurich, Dean T., Yuksel, Nesé
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359830/ https://www.ncbi.nlm.nih.gov/pubmed/28320467 http://dx.doi.org/10.1186/s12905-017-0370-6

Ejemplares similares

Hormone Levels and Sexual Functioning After Risk-Reducing Salpingo-Oophorectomy
por: Johansen, Nora, et al.
Publicado: (2018)

Bone density loss after risk reducing salpingo-oophorectomy
por: Andrews, L, et al.
Publicado: (2012)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Transvaginal laparoscopic salpingo-oophorectomy: an oncological risk-reducing procedure
por: Lathouras, Kostas, et al.
Publicado: (2019)

Risk-Reducing Salpingo-Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause
por: Manchanda, R, et al.
Publicado: (2022)

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer
por: Lee, Y. C., et al.
Publicado: (2017)

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
por: Feng, Zheng, et al.
Publicado: (2023)

“Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty”
por: Malacarne, Dominique R., et al.
Publicado: (2017)

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy
por: Teixeira, Natalia, et al.
Publicado: (2018)

Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO)
por: Pross, Therese, et al.
Publicado: (2021)

Risk-reducing Salpingo-oophorectomy consults and practices during the COVID-19 pandemic
por: O'Mara, A.E., et al.
Publicado: (2022)

Laparoscopic Salpingo-oophorectomy in Conscious Sedation
por: Rosati, Maurizio, et al.
Publicado: (2015)

A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients
por: Loizzi, Vera, et al.
Publicado: (2022)

Impact of lower co-payments on risk-reducing salpingo-oophorectomy and BRCA testing in Japan
por: Konnai, Katsuyuki, et al.
Publicado: (2023)

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation
por: Jung, Sung Mi, et al.
Publicado: (2020)

The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy
por: van der Aa, Jessica E., et al.
Publicado: (2015)

Changes in Sex Steroids and Relation With Menopausal Complaints in Women Undergoing Risk-reducing Salpingo-oophorectomy
por: van Winden, Lennart J, et al.
Publicado: (2022)

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
por: Sekine, Masayuki, et al.
Publicado: (2021)

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
por: Steenbeek, Miranda P, et al.
Publicado: (2023)

Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea
por: Park, Boyoung, et al.
Publicado: (2022)

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
por: Fakkert, Ingrid E., et al.
Publicado: (2017)

Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
por: Park, Sun-young, et al.
Publicado: (2020)

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy
por: Menkiszak, Janusz, et al.
Publicado: (2019)

Metastatic ovarian carcinoma in breast cancer patients during risk-reducing salpingo-oophorectomy: Report of two cases
por: Shakya, Prafulla, et al.
Publicado: (2021)

Feasibility of Risk Reducing Salpingo-Oophorectomy at the Time of Abdominal Surgery for Correction of Pelvic Organ Prolapse and Urinary Incontinence
por: Azadi, Ali, et al.
Publicado: (2021)

Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan
por: Nomura, Hidetaka, et al.
Publicado: (2023)

Long-Term Non-Cancer Risks in People with BRCA Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review
por: Nitschke, Amanda S., et al.
Publicado: (2023)

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy
por: Chen, Hao, et al.
Publicado: (2016)

Analysis of Prophylactic Salpingo-oophorectomy at the Time of Hysterectomy for Benign Lesions
por: Jain, Sheela Hemant, et al.
Publicado: (2019)

Contralateral ovarian endometrioma recurrence after unilateral salpingo-oophorectomy
por: Hidari, Tokie, et al.
Publicado: (2019)

Bilateral Salpingo-Oophorectomy for Intracardiac Leiomyomatosis: A Case Report
por: Liang, Jinxiao, et al.
Publicado: (2022)

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
por: Rebbeck, Timothy R., et al.
Publicado: (2009)

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study
por: Harmsen, Marline G., et al.
Publicado: (2015)

Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm
por: Gasparri, Maria Luisa, et al.
Publicado: (2019)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
por: Mavaddat, Nasim, et al.
Publicado: (2020)

An explainable machine learning ensemble model to predict the risk of ovarian cancer in BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy
por: Comes, Maria Colomba, et al.
Publicado: (2023)

Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis
por: Gaba, Faiza, et al.
Publicado: (2023)

Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence
por: Conduit, Ciara, et al.
Publicado: (2021)

Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO)
por: Stanciu, P. I., et al.
Publicado: (2019)

Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study
por: Gaba, Faiza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_al855dt2h7la9aipclfje2keej